Results 141 to 150 of about 1,978,294 (292)
Risk factors for post TRUSPBx infectious complications.
, 2017 Risk factors for post TRUSPBx infectious complications.
Emanuele Montanari (759655) +7 more
core +1 more source
Severe Acute Respiratory Syndrome by COVID-19 in pregnant and postpartum women
Revista Brasileira de Saúde Materno InfantilObjectives: to evaluate the morbidity and mortality profile and factors associated with death due to severe acute respiratory syndrome (SARS) by COVID-19 in pregnant and postpartum women.
Ana Paula Nogueira Godoi +6 more
doaj +2 more sources
Identification of risk factors influencing pregnancy complications development
According to the WHO, about 830 women die every day worldwide from preventable causes related to pregnancy and childbirth. In the recent years, Kharkiv region remains one of the problematic regions of adverse pregnancy outcomes according to the ...
Ohniev, V., Orel, O.
core +1 more source
Implementation and use of risk minimization control tools in the EU: A multistakeholder survey
British Journal of Clinical Pharmacology, EarlyView.Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink +21 more
wiley +1 more source
Turkish Journal of Family PracticeInfluenza is a major public health concern that can cause infection in all age groups while leading to severe complications, hospitalization, and mortality particularly in the presence of risk factors such as advanced age, chronic comorbidities ...
Güzin Zeren Öztürk +4 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley +1 more source
Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy
, 2018 Yu-Peng Wu,* Xiao-Dong Li,* Zhi-Bin Ke,* Shao-Hao Chen, Ping-Zhou Chen, Yong Wei, Jin-Bei Huang, Xiong-Lin Sun, Xue-Yi Xue, Qing-Shui Zheng, Ning Xu Department of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China *These ...
Li XD +10 more
core
British Journal of Clinical Pharmacology, EarlyView.Aims Almost 5% of pregnancies are affected by immune‐mediated inflammatory diseases (IMIDs). As treatments become available, understanding their use during pregnancy is important. We aimed to describe maternal, pregnancy and infant outcomes among IMID pregnancies exposed to biologic therapies. Methods Using the Merative™ MarketScan® Commercial Database,
Leah K. Flatman +3 more
wiley +1 more source
Antibacterial therapy in preterm labor and prelabor rupture of fetal membranes
RUDN Journal of Medicine, 2011 Preterm labor and prelabor rupture of fetal membranes is one of the most challenging and contradictory problems of obstetrics. From one hand, prolongation of preterm pregnancy increases the gestational age of the fetus.
K S Podtetenev +5 more
doaj
The placental transfer of nirmatrelvir using the ex vivo human placental perfusion model
British Journal of Clinical Pharmacology, EarlyView.Aims Nirmatrelvir is an effective therapeutic option for COVID‐19 infection and is often administered after symptom onset in pregnant individuals, but few data are available on the associated fetal exposure. The placental perfusion model evaluates maternal–fetal drug transfer across the human placenta and thus can determine fetal drug exposure.
Magdalene Zabek +5 more
wiley +1 more source